摘要
目的研究阿魏酸对脂多糖(LPS)与干扰素-γ(IFN-γ)诱导巨噬细胞M1极化的影响与作用机制。方法THP-1细胞加入佛波酯(PMA)诱导成M0型巨噬细胞,使用LPS+IFN-γ诱导成M1型巨噬细胞。采用CCK-8法确定阿魏酸对M1型巨噬细胞的实验浓度范围;流式细胞术检测阿魏酸对M1型巨噬细胞极化情况;酶联免疫吸附实验(ELISA)和实时荧光定量PCR法检测阿魏酸对M1型巨噬细胞分泌产物肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)mRNA和蛋白表达的影响;Western blot法检测p38 MAPK、p38 MAPK磷酸化(p-p38 MAPK)蛋白表达水平的变化。结果阿魏酸浓度在80μmol/L以下对M1型巨噬细胞的活性无影响。在阿魏酸作用下,与对照组比较,M1型巨噬细胞标志物CD80+的表达显著降低(P<0.05);同时,阿魏酸能抑制M1型巨噬细胞分泌的TNF-α、IL-1β和p38 MAPK磷酸化(p-p38 MAPK)蛋白表达,其作用呈剂量依赖性。结论阿魏酸抑制M0型巨噬细胞向M1型极化,降低促炎因子表达,其抗炎作用机制与抑制p38 MAPK信号通路活化有关。
Objective To study the effect and mechanism of ferulic acid on M1 polarization of macrophages induced by LPS and IFN-γ.Methods THP-1 cells were induced into M0 type macrophages by adding PMA,and M1 type macrophages were induced using LPS+IFN-γ.The concentration range of ferulic acid on M1 macrophages was determined by CCK-8 method.Flow cytometry was used to detect the polarization of M1 macrophages induced by ferulic acid.ELISA and real-time quantitative PCR were used to detect the effects of ferulic acid on the expression of tumor necrosis factor-α(TNF-α)and interleukin-1β(IL-1β)mRNA and protein by M1 type macrophages.Western blot was used to detect the expression of p38 MAPK and p-p38 MAPK.Results Ferulic acid concentration below 80μmol/L had no effect on the activity of M1 type macrophages.Compared with the control group,the expression of M1 type macrophage marker CD80+was significantly decreased under ferulic acid treatment(P<0.05).Ferulic acid also inhibited the expression of TNF-α,IL-1βand p-p38 MAPK by M1 type macrophages in a dose-dependent manner.Conclusion Ferulic acid can inhibit the polarization of M0 macrophages towards M1 type and reduce the expression of pro-inflammatory factors,which is related to the inhibition of p38 MAPK signaling pathway.
作者
韦子强
张雯雯
郭嘉亮
罗文汇
郑兆广
刘正
谢倩
曾煦欣
WEI Ziqiang;ZHANG Wenwen;GUO Jialiang;LUO Wenhui;ZHENG Zhaoguang;LIU Zheng;XIE Qian;ZENG Xuxin(Foshan University,Foshan 528000,China;Guangdong Yifang Pharmaceutical Co.Ltd,Foshan 528000,China;Foshan Pharmaceutical Association,Foshan 528000,China)
出处
《广东药科大学学报》
CAS
2023年第3期68-72,共5页
Journal of Guangdong Pharmaceutical University
基金
广东省基础与应用基础研究基金自然科学基金项目(2019A1515010806)
广东省示范性产业学院(粤教高函[2020]21号)
广东省教育厅重点领域专项(2020ZDZX2057)
佛山市工程技术研究中心项目(2017GA00025)。